Update shared on05 Sep 2025
With STERIS’s discount rate and future P/E both virtually unchanged, analyst valuation perspectives remain steady, resulting in an unchanged consensus price target of $272.38.
What's in the News
- STERIS completed $200 million in share repurchases, totaling 907,158 shares (0.92%) under its current buyback program; no additional shares were repurchased in the latest quarter.
- Chief Financial Officer Michael J. Tokich will step down, with Karen L. Burton succeeding him on August 18, 2025; Tokich will become Senior Financial Advisor.
- Fiscal 2026 reported revenue growth guidance increased to 8-9% from 6-7%, driven by improved currency outlook; constant currency organic revenue growth guidance maintained at 6-7%.
- Quarterly dividend raised to $0.63 per share, marking the 20th consecutive year of dividend increases.
- STERIS was removed from the Russell 1000 Dynamic Index.
Valuation Changes
Summary of Valuation Changes for STERIS
- The Consensus Analyst Price Target remained effectively unchanged, at $272.38.
- The Discount Rate for STERIS remained effectively unchanged, moving only marginally from 7.65% to 7.64%.
- The Future P/E for STERIS remained effectively unchanged, moving only marginally from 32.68x to 32.66x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.